immatics biotechnologies GmbH logo
immatics biotechnologies GmbH IMTXW
$ 0.19 -24.0%

Quarterly report 2022-Q2
added 08-09-2022

report update icon

immatics biotechnologies GmbH Balance Sheet 2011-2024 | IMTXW

Annual Balance Sheet immatics biotechnologies GmbH

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- - - - - - - - - - -

Long Term Debt

- - - - - - - - - - -

Long Term Debt Current

- 1.88 M 1.41 M - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - -

Total Current Liabilities

- - - - - - - - - - -

Total Liabilities

- - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - -

Retained Earnings

- - - - - - - - - - -

Total Assets

- - - - - - - - - - -

Cash and Cash Equivalents

- 208 M 103 M 39.4 M 8.42 M - - - - - -

Book Value

- - - - - - - - - - -

Total Shareholders Equity

- 87.4 M -40.8 M -9.17 M -2.26 M - - - - - -

All numbers in EUR currency

Quarterly Balance Sheet immatics biotechnologies GmbH

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - 14 M - 7.14 M - 4.74 M - 4.31 M - - - 1.82 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - 129 M - 55.4 M - 66.9 M - 89.8 M - - - 106 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

- - - - - - 161 M - 167 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

- - -466 M - -538 M - -494 M - -444 M - - - -233 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

- - 368 M - 175 M - 217 M - 255 M - - - 134 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

- - 265 M - 133 M - 160 M - 208 M - 86.1 M - 103 M - - - 39.4 M - - - 8.42 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

- - 368 M - 175 M - 55.6 M - 87.4 M - - - 134 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

- - 125 M - 24.1 M - 55.6 M - 87.4 M - -68 M - -40.8 M - - - -9.17 M - - - -2.26 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in EUR currency